<?xml version="1.0" encoding="UTF-8"?>
<p>The target population consists of patients hospitalized with the coronavirus. The eligible patients, based on the inclusion criteria, will be informed about the purpose of study. Then an assistant researcher will collaborate to obtain the written informed consent. It will be ensured that participants can withdraw from the study any time they wish with no effect on their subsequent care. The informed consent has already been evaluated by the Ethics Committee of MUMS (Ethical code: IR.MUMS.REC.1399.118).</p>
